I'm not having a go at you Itsa, i am just saying its not possible for basically anyone to accurately predict pricing in this situation.
I don't have a problem with speculation, by anyone, but I do think that others (readers) shouldn't expect it to be accurate.
Also, to clear something up I have seen posted over time, the FDA and Fast track etc don't validate a product, science does that, Fast track can validate a program, but not a product. Two different things.
And the Broker reports are educated guesstimates, you can see that they are often not where the market is. It is quite possible and often does have a situation where the tail wags the dog, and the more tails the more they wag.
This is the market.
Product, revenue, expenses allow for quite accurate projection, no product and we are is at the whim of the market, just how it is.
Again, I have no problem with speculation, especially post product, but pre product I look at speculative pricing more humorously, and sometimes some people get lucky and can be quite aligned to the market, good on them.
ANP Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
